Zurueck zur Suche

Reporte zur Charge U015688

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 VA 1 MO 1 TX 1

VAERS 2151243

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015688

mild
Staat
MI
Alter
5,0
Geschlecht
M
Eingang
01.03.2022
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pruritus Injection site rash Urticaria

Symptomtext

Immediate Hives, rash and itching at injection site that spread up to the top of the thigh and around the back of the thigh. 5ml of benadryl was given. Reaction started to subside after 15 minutes of receiving benadryl.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
dust mites
Vorherige Impfungen
-

VAERS 2409338

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015688

gering
Staat
VA
Alter
27,0
Geschlecht
U
Eingang
12.08.2022
Impfdatum
04.08.2022
Beginn
04.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

No additional adverse event; Caller reports VARIVAX administered IM to a 27yo.; This spontaneous report was received from a nurse and refers to a 27-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 04-AUG-2022, the patient received a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot # U015688, expiration date: 18-MAY-2023, that was administered intramuscularly for prophylaxis (anatomical location was not provided) (Incorrect route of product administration). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2400472

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015688

gering
Staat
MO
Alter
1,1
Geschlecht
F
Eingang
03.08.2022
Impfdatum
03.08.2022
Beginn
03.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

Pt was given vaccine IM instead of SubQ. No adverse outcomes known at this time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 2256092

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015688

gering
Staat
TX
Alter
1,9
Geschlecht
F
Eingang
28.04.2022
Impfdatum
11.04.2022
Beginn
11.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; VARIVAX was administered after a temperature excursion; This spontaneous report has been received from a medical assistant referring to a 23-month-old female patient. The patient's pertinent medical history, previous drug reactions or allergies, concurrent conditions, and concomitant therapies were not reported. On 11-APR-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliters (ml) (route of administration, anatomical site of vaccination, and vaccine scheme were not reported; lot number U015688 has been verified to be valid, expiration date reported and established as 18-MAY-2023) as prophylaxis. It was reported that the vaccine was exposed to a temperature excursion of 12.95 degrees Fahrenheit (F), during a time frame of 21 hours and 15 minutes before it was administered to the patient (product storage error). No additional adverse event was reported (no adverse event). No previous temperature excursion was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1892617

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015688

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
23.11.2021
Impfdatum
07.10.2021
Beginn
24.10.2021
Tage bis Beginn
17,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

No additional AE reported; VARIVAX was administered again 9NOV2021; Patient had MMRII vaccine administered 7OCT2021. Pateient then had VARIVAX administered on 24OCT2021, before 28 days; This spontaneous information was received from a nurse concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. On 07-OCT-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (strength, dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided). On 24-OCT-2021 the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml for prophylaxis (lot number: U015688 with expiration date on 18-MAY-2023) (strength, frequency, route of administration and anatomical location were not provided) before 28 days (inappropriate schedule of product administration). Additionally, on 09-NOV-2021, the patient was vaccinated again with varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (strength, dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided) (inappropriate schedule of product administration). No additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-